Retrovirus-mediated gene transfer in cancer therapy

Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Straβe 10, 13122 Berlin, Germany
Pharmacology [?] Therapeutics (Impact Factor: 9.72). 10/1994; 63(3):323-347. DOI: 10.1016/0163-7258(94)90029-9


Retroviral vectors are one of the most promising systems for the transfer and the expression of therapeutic genes in human gene therapy protocols. This review will focus both on the advantages and intricacies of retroviral vectors themselves as well as on the application of these vector systems in experimental and clinical cancer therapy protocols. Therefore, the retrovirus life cycle and the general features of retroviral vectors, including possible targeting strategies with retroviral vectors, are overviewed. These topics are followed by the presentation of genes with emphasis on their potential as tools in somatic cell cancer therapy (cytokines, lymphokines, colony-stimulating growth factors, suppressor genes, antisense oncogenes, suicide genes). Finally, a prospect on the application of retroviral vectors will be described.

5 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cancer still represents a disease of high incidence and is therefore one major target for gene therapy approaches. Gene therapy for cancer implies that ideally selective tumor cell killing or inhibition of tumor cell growth can be achieved using nucleic acids (DNA and RNA) as the therapeutic agent. Therefore, the majority of cancer gene therapy strategies introduce foreign genes into tumor cells which aim at the immunological recognition and destruction, the direct killing of the target cells or the interference with tumor growth. To achieve this goal for gene therapy of cancer, a broad variety of therapeutic genes are currently under investigation in preclinical and in clinical studies. These genes are of very different origin and of different mechanisms of action, such as human cytokine genes, genes coding for immunstimulatory molecules/antigens, genes encoding bacterial or viral prodrug-activating enzymes (suicide genes), tumor suppressor genes, or multidrug resistance genes.
    Molecular Biotechnology 11/1999; 13(1):21-28. DOI:10.1385/MB:13:1:21 · 1.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Geographic ranges are estimated for brachiopod and bivalve species during the late Middle (mid-Givetian) to the middle Late (terminal Frasnian) Devonian to investigate range changes during the time leading up to and includ- ing the Late Devonian biodiversity crisis. Species ranges were predicted using GARP (Genetic Algorithm using Rule-set Prediction), a modeling program developed to predict fundamental niches of modern species. This method was applied to fossil species to examine changing ranges during a critical period of Earth's history. Comparisons of GARP species distribution predictions with historical understanding of species occurrences indi- cate that GARP models predict accurately the presence of common species in some depositional settings. In addi- tion, comparison of GARP distribution predictions with species-range reconstructions from geographic information systems (GIS) analysis suggests that GARP modeling has the potential to predict species ranges more completely and tailor ranges more specifically to environmental parameters than GIS methods alone. Thus, GARP modeling is a potentially useful tool for predicting fossil species ranges and can be used to address a wide array of palaeontological problems. The use of GARP models allows a statistical examination of the relationship of geographic range size with species survival during the Late Devonian. Large geographic range was statistically associated with species sur- vivorship across the crisis interval for species examined in the linguiformis Zone but not for species modeled in the preceding Lower varcus or punctata zones. The enhanced survival benefit of having a large geographic range, therefore, appears to be restricted to the biodiversity crisis interval.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Abstract Abstract Abstract Abstract AIM:T o investigate the effect of bromocriptine(BCT) and tumor necrosis factor-α(TNF- α) on hepatocellular carcinoma (HCC) multidrug resistance (MDR) in nude mouse MDR model of liver neoplasm. METHODS: Human hepatocarcinoma cell line HepG2, drug
Show more

Similar Publications